Skip to main content

Novel Endoscopic Antireflux Procedures: Do They Have a Role in Patients with Hiatus Hernia?

  • Chapter
  • First Online:
Hiatal Hernia Surgery
  • 1036 Accesses

Abstract

Endoscopic anti-reflux therapy (EART) is a relatively novel concept in the management of gastro-esophageal reflux disease (GERD) that intends to address three key issues: First, the need to treat refractory GERD, that is, to eliminate symptoms that are not completely controlled by proton pump inhibitor (PPI) use; second to eliminate long-term PPI use in those patients who, although well-controlled pharmacologically, are concerned about drug-related adverse events; and third to minimize the need for laparoscopic anti-reflux surgery (LARS) and its peri-operative and long-term sequelae [1]. Over the past 15 years, these clinical issues have become increasingly prevalent and clinically significant, thereby expanding the potential applicability and clinical value of EART. It has also become clear that not all patients with GERD are suitable candidates for such an option and that a careful, objective evaluation is needed in order to phenotypically characterize the disease and tailor therapy, aiming at producing the best long-term efficacy and safety.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

ARMS:

Anti-reflux mucosectomy

EART:

Endoscopic anti-reflux therapy

GEJ:

Gastro-esophageal junction

GERD:

Gastroesophageal reflux disease

GERD-HRQL:

GERD health related quality of life

LARS:

Laparoscopic antireflux surgery

LESP:

Lower esophageal sphincter pressure

PPI:

Proton pump inhibitors

TF:

Transoral fundoplication

References

  1. Triadafilopoulos G. Endoscopic options for gastroesophageal reflux: where are we now and what does the future hold? Curr Gastroenterol Rep. 2016;18(9):47. https://doi.org/10.1007/s11894-016-0521-1.

    Article  PubMed  Google Scholar 

  2. de Bortoli N, Martinucci I, Bertani L, Russo S, Franchi R, Furnari M, Tolone S, Bodini G, Bolognesi V, Bellini M, Savarino V, Marchi S, Savarino EV. Esophageal testing: what we have so far. World J Gastrointest Pathophysiol. 2016;7(1):72–85. https://doi.org/10.4291/wjgp.v7.i1.72.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus. 2013;26(5):443–50. https://doi.org/10.1111/j.1442-2050.2012.01381.x.

    Article  CAS  PubMed  Google Scholar 

  4. Bedell A, Taft TH, Keefer L, Pandolfino J. Development of the northwestern esophageal quality of life scale: a hybrid measure for use across esophageal conditions. Am J Gastroenterol. 2016;111(4):493–9. https://doi.org/10.1038/ajg.2016.20.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, Perry KA, Oelschlager BK, Soper NJ, Snyder BE, Burch MA, Melvin WS, Reavis KM, Turgeon DG, Hungness ES, Diggs BS. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–333.e5. https://doi.org/10.1053/j.gastro.2014.10.009.

    Article  CAS  PubMed  Google Scholar 

  6. Ouyang W, Dass C, Zhao H, Kim C, Criner G. COPDGene Investigators. Multiplanar MDCT measurement of esophageal hiatus surface area: association with hiatal hernia and GERD. Surg Endosc. 2016;30(6):2465–72. https://doi.org/10.1007/s00464-015-4499-9.

    Article  PubMed  Google Scholar 

  7. Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74. https://doi.org/10.1111/nmo.12477.

    Article  CAS  PubMed  Google Scholar 

  8. Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE, Pope CE II. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc. 1996;44(5):541–7.

    Article  CAS  PubMed  Google Scholar 

  9. Singhal V, Khaitan L. Preoperative evaluation of gastroesophageal reflux disease. Surg Clin North Am. 2015;95(3):615–27. https://doi.org/10.1016/j.suc.2015.02.013.

    Article  PubMed  Google Scholar 

  10. Lin DC, Chun CL, Triadafilopoulos G. Evaluation and management of patients with symptoms after anti-reflux surgery. Dis Esophagus. 2015;28(1):1–10. https://doi.org/10.1111/dote.12103.

    Article  PubMed  Google Scholar 

  11. Iannelli A, Sans A, Martini F, Santonicola A, Iovino P, Angrisani L. Hiatal hernia, GERD, and sleeve gastrectomy: a complex interplay. Obes Surg. 2016;26(10):2485–7. https://doi.org/10.1007/s11695-016-2291-0.

    Article  PubMed  Google Scholar 

  12. Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014;20:7730–8. https://doi.org/10.3748/wjg.v20.i24.7730.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Triadafilopoulos G, Azagury D. How can we deal with the GERD treatment gap? Ann N Y Acad Sci. 2016;1381(1):14–20. https://doi.org/10.1111/nyas.13104.

    Article  PubMed  Google Scholar 

  14. Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323–33.

    Article  PubMed  Google Scholar 

  15. Arts J, Bisschops R, Blondeau K, Farré R, Vos R, Holvoet L, Caenepeel P, Lerut A, Tack J. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107:222–30.

    Article  CAS  PubMed  Google Scholar 

  16. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, Edmundowicz S, Kline M, Mason R, Wolfe MM. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125:668–76.

    Article  PubMed  Google Scholar 

  17. Aziz AM, El-Khayat HR, Sadek A, Mattar SG, McNulty G, Kongkam P, Guda MF, Lehman GA. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:818–25.

    Article  PubMed  Google Scholar 

  18. Cadière GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22:333–42. https://doi.org/10.1007/s00464-007-9618-9.

    Article  PubMed  Google Scholar 

  19. Håkansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, Lerhun M, Coron E, Tack J, Bischops R, Thorell A, Arnelo U, Lundell L. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42:1261–70. https://doi.org/10.1111/apt.13427.

    Article  PubMed  Google Scholar 

  20. Witteman BPL, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, Stassen LPS, Bouvy ND. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110:531–42. https://doi.org/10.1038/ajg.2015.28.

    Article  CAS  PubMed  Google Scholar 

  21. Testoni PA, Vailati C. Transoral incisionless fundoplication with EsophyX® for treatment of gastro-oesphageal reflux disease. Dig Liver Dis. 2012;44:631–5. https://doi.org/10.1016/j.dld.2012.03.019.

    Article  PubMed  Google Scholar 

  22. Repici A, Fumagalli U, Malesci A, Barbera R, Gambaro C, Rosati R. Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg. 2010;14:1–6. https://doi.org/10.1007/s11605-009-1077-2.

    Article  PubMed  Google Scholar 

  23. Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, Kessler WR, Selzer DJ, Broderick RC, Lehman GA, Horgan S. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220–9.

    Article  PubMed  Google Scholar 

  24. Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, Hayee B, Eleftheriadis N, Kudo SE. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27:346–51.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George Triadafilopoulos M.D. .

Editor information

Editors and Affiliations

Ethics declarations

Conflict of Interest: The author has equity position with Mederi Therapeutics, C2 Therapeutics and EndoStim.

Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by the author.

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Triadafilopoulos, G. (2018). Novel Endoscopic Antireflux Procedures: Do They Have a Role in Patients with Hiatus Hernia?. In: Memon, M. (eds) Hiatal Hernia Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-64003-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64003-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64002-0

  • Online ISBN: 978-3-319-64003-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics